Conduent ((CNDT)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Conduent’s latest earnings call struck a cautious but constructive note as management balanced clear progress on profitability and sales momentum with persistent headwinds in revenue and cash flow. Leadership framed 2025 as the early phase of a multi‑year turnaround, stressing tighter execution, cost discipline, and a sharper focus on higher‑margin government and transportation work.
ACV Growth and Pipeline Strength
Conduent highlighted solid demand indicators, with qualified ACV at $3.2 billion, up about 4% year over year, and Q4 new business ACV rising 11%. Full‑year 2025 new ACV reached $517 million, up 6%, while the government qualified pipeline jumped roughly 29%, and the in‑year 2026 pipeline is nearly double the level seen at the start of 2025.
New Logos and Capability Expansion
Sales activity broadened meaningfully as the company signed 14 new logos and 20 new capabilities in Q4, bringing the full‑year totals to 41 new clients and 87 capabilities. New business TCV for 2025 is up about 16% versus 2024, and new capability ACV surged roughly 60%, signaling healthier cross‑sell and product‑driven growth potential.
EBITDA Growth and Margin Gains
Profitability improved despite lower revenue, with full‑year adjusted EBITDA rising to $164 million from $124 million and margins climbing 150 basis points to 5.4%. In Q4, the adjusted EBITDA margin reached 6.5%, up 250 basis points year over year and 130 basis points sequentially, underscoring early benefits from cost actions and mix shifts.
Government and Transportation Profitability
At the segment level, government delivered adjusted EBITDA of $221 million and a robust 24% margin, up about 270 basis points from the prior year. Transportation revenue grew 3.9%, and its adjusted EBITDA margin improved by roughly 300 basis points to 3%, reflecting better pricing, volume trends, and operational efficiency.
Lower Corporate Overheads
Corporate cost cuts supported the margin story, with unallocated expenses falling to $229 million, a reduction of roughly 10.2% versus 2024. Management attributed the savings to ongoing efficiency programs and the recovery of certain legal costs, and signaled further scrutiny of non‑client‑facing spending.
Leverage Improvement and Capital Discipline
The net leverage ratio improved to 2.8 times as the company leaned into capital discipline despite negative free cash flow. Capital expenditures were kept near 3.4% of revenue, and management reiterated that proceeds from planned portfolio rationalization will be directed first to paying down debt.
Q4 Cash Flow Positives Amid Annual Deficit
Cash generation showed signs of stabilization in the fourth quarter, with adjusted free cash flow turning positive at $28 million even though it came in lower than expected. Management emphasized that some large contract receipts slipped into early 2026 and now anticipate collections in the first quarter or early second quarter.
AI and Product‑Led Efficiency
Artificial intelligence is emerging as a tangible driver of efficiency, particularly in the government segment where it has helped reduce fraud and lower labor and telecom costs. In transportation, the Fairgate product is moving toward deployment in New York City’s transit system, with management positioning it as a scalable platform for broader rollout.
Revenue Decline Weighs on the Top Line
Despite operational gains, revenue pressure remained a core concern as adjusted sales for 2025 declined to $3.04 billion from $3.18 billion, a drop of about 4.2%. The company is working to offset these declines through new wins and capabilities, but the near‑term growth profile remains constrained.
Commercial Segment Weakness
The commercial business underperformed, with adjusted revenue falling to $1.5 billion, down roughly 5.9% year over year, and margins slipping about 30 basis points to 10.2%. Volume declines at a handful of large clients, including one particularly sizable customer, accounted for around 40% of the segment’s revenue drop.
Negative Annual Free Cash Flow
For the full year, adjusted free cash flow was a negative $130 million, reflecting timing issues tied to big implementations and delayed collections on certain contracts. Management expects some of this cash to arrive in early 2026 but acknowledged that converting EBITDA improvements into steady free cash flow remains a key challenge.
Working Capital and Receivables Strain
Year‑end working capital trends also weighed on the balance sheet, with contract assets declining while accounts receivable increased due to delayed contract amendments and billing. These timing issues hurt the company’s year‑end cash position and will be a focus area as management tightens discipline around collections.
Cost Pressures and Implementation Wind‑Downs
Operating costs were mixed, as higher U.S. employee healthcare claims offset some of the benefits from corporate cost reductions. In addition, several large implementations wound down, trimming revenue and leaving the company reliant on new deal ramp‑ups to backfill lost volume.
Customer Concentration Risks
The call underscored notable customer concentration, with performance heavily influenced by a small group of large commercial clients and one especially impactful account. Management was candid that the commercial segment will require a turnaround effort and may not return to growth in 2026, elevating execution risk.
Exposure to Technological Disruption
Management estimated that roughly 15% to 20% of Conduent’s business could face disruption from AI‑driven and technology competitors, putting existing contracts and pricing under pressure. The company aims to move quickly by partnering or building new capabilities to defend margins and reposition its offerings.
Limited Near‑Term Guidance and Uncertainty
With a new CEO in the role for less than a month, Conduent refrained from issuing full 2026 guidance and flagged continued uncertainty around portfolio actions and cash recovery. Clearer direction on the timing and impact of the fix‑sell‑grow strategy, as well as more concrete free cash flow targets, is slated for the next quarter.
Turnaround Roadmap and Outlook
Looking ahead, management outlined a turnaround plan centered on faster execution, tighter financial discipline, cost cuts, and portfolio rationalization, with an upcoming Analyst Day expected to provide more detail. They aim to materially lift steady‑state margins toward an 8% to 10% floor and sharpen the conversion of EBITDA into sustainable free cash flow, with full 2026 guidance due alongside Q1 results.
Conduent’s earnings call painted a company at an early but decisive stage of a turnaround, with encouraging signs in ACV growth, pipeline quality, and margin expansion set against declining revenue and negative free cash flow. For investors, the story hinges on whether management can convert a growing backlog and cost efficiencies into durable growth and cash generation while navigating customer and technology risks.

